Your browser doesn't support javascript.
loading
ß2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk.
Liu, Bojing; Svenningsson, Per; Ludvigsson, Jonas F; Lundholm, Cecilia; Wallin, Johan; Larsson, Henrik; Sjölander, Arvid; Williams, Dylan M; Pedersen, Nancy L; Wirdefeldt, Karin.
Affiliation
  • Liu B; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Svenningsson P; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • Ludvigsson JF; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Lundholm C; Department of Pediatrics, Örebro University Hospital, Örebro, Sweden.
  • Wallin J; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Larsson H; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • Sjölander A; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Williams DM; School of Medical Sciences, Örebro University, Örebro, Sweden.
  • Pedersen NL; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Wirdefeldt K; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Ann Neurol ; 93(5): 1023-1028, 2023 05.
Article in En | MEDLINE | ID: mdl-36897287
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Quinolines Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Neurol Year: 2023 Type: Article Affiliation country: Sweden
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Quinolines Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Neurol Year: 2023 Type: Article Affiliation country: Sweden